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Abstract
Background: Diet is strongly associated with the aetiology of Crohn’s Disease (CD) and exclusive enteral nutrition
(EEN) is the primary induction treatment in paediatric CD. This study explored opinions around the use of EEN and
alternative novel, solid food-based diets (SFDs) expressed by paediatric patients with CD, previously treated with
EEN and their parents.
Methods: This anonymous questionnaire surveyed families of CD patients treated with EEN over 1 year. Two
questionnaire forms were completed; one asking the patients’ opinions and another referring to their main carer.
This questionnaire explored participants’ demographic characteristics; acceptability of a repeat EEN course to treat a
future flare (EEN repeat); their opinion on how difficult EEN would be compared to an example SFD; and their
intention to participate in a future clinical trial assessing the therapeutic efficacy of an SFD in CD.
Results: Forty-one families of CD patients were approached with 29 sending replies (71%). Most of our participants
were positive on completing another EEN course, however the majority would choose an SFD alternative (Patients:
66, Parents:72%). Both patients and their parents rated EEN to be more difficult to adhere to compared to an example
SFD (p < 0.05), and their ratings were strongly correlated (EEN:r = 0.83, SFD:r = 0.75, p < 0.001). The majority of our
respondents would agree to participate in a clinical trial assessing an SFD’s effectiveness (Patients:79, Parents:72%) for
the management of active CD.
Conclusions: While patients with CD and their families would accept an EEN repeat, the majority would prefer an SFD
alternative. CD families surveyed are supportive of the development of solid food-based dietary treatments.
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Background
Crohn’s disease (CD) is an incurable chronic inflammatory
condition of the gut. It causes severe gastrointestinal and
extraintestinal complications and is associated with high
morbidity, poor quality of life and increased health
expenditure [1].
The medical treatment for induction and mainten-
ance of CD remission includes anti-inflammatory and
immunomodulatory medication [2], whereas exclusive
enteral nutrition (EEN) is established as the primary
induction treatment in paediatric CD. EEN induces
both mucosal and transmural healing, has up to 80%
remission rates and an excellent safety profile [3]. It
is however potentially restrictive and can be difficult to ad-
here to for long periods of time with compliance and palat-
ability issues limiting its use especially in adult patients [4].
The strong and sustained patient interest on the role
of diet in CD has been described in the literature [5].
This is also reflected by the high usage of complemen-
tary and alternative medicine among CD patients, with
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dietary modifications being among the most common
therapies used [6]. Additionally, emerging evidence is in-
dicating potential clinical efficacy of exclusion solid
food-based diets (SFDs) [7–13].
These facts pose a pressing need and clinical demand to
explore patients’ perceptions on the use of EEN and the
introduction of novel SFDs for use in routine clinical prac-
tice. The aim of this questionnaire survey was therefore to
report the beliefs of carers and paediatric CD patients,
previously treated with EEN, on the acceptability of such
dietary treatments, including within a research context.
Methods
Recruitment of families with CD children
An anonymous questionnaire survey was posted to all
families of paediatric CD patients who had been treated
with a previously described EEN protocol [14] during
2015 by the IBD team at the Royal Hospital for Children
in Glasgow (RHCG). Two questionnaire forms were
included: one asking the patients’ opinions and another
referring to their main carer (hereafter “parent”). A
stamped addressed envelope was provided for the return
of the questionnaires and a reminder was sent out
2 months later to increase response rate. Both the initial
posted envelope and the reminder included a cover let-
ter explaining the reason of this questionnaire survey,
but also instructing the parents and patients to complete
the questionnaires separately (see Additional file 1).
Questionnaire
A draft questionnaire was compiled by senior medical
and dietetic staff who look after patients with CD. The
content validity of the survey was then checked by mem-
bers of the IBD team at RHCG and its readability by lay
people (see Additional files 2 and 3). The survey
collected information on participants’ demographic
characteristics, the acceptability of an EEN repeat, and
their opinion on how difficult it was to undertake an
EEN course or it would be to undertake an example
SFD provided to them (using visual analogue scales,
translated to a scale from 1 to 100; see Q7 and Q13 of
Additional file 2). It also investigated their intention to
participate in a future clinical trial assessing the thera-
peutic efficacy of an SFD in CD. The questions asked in-
cluded both open-ended and multiple-choice and we
explicitly asked the participants for any further com-
ments on their previous EEN experience or the use of
an SFD. These comments were categorised as positive,
negative or neutral by the investigators. The SFD was a
diet template (see Additional files 2 and 3) describing an
alternative exclusion diet. We ensured that no specific
dietary advice was disclosed in this example template
and made a specific statement on this matter.
Recruitment of adult CD patients
Following the same approach as described above we
identified adult CD patients, treated with EEN by the
IBD team at the Glasgow Royal Infirmary in Glasgow.
Statistical analysis
Categorical responses are presented with numbers and
frequencies (%). Differences between ratings of the two
diets by the participants were compared with 1-sample
Wilcoxon signed-rank test. Correlations of parents’ and
patients’ ratings were tested with Spearman’s rank cor-
relation. Statistical analysis was performed with Minitab
16 (Minitab Ltd, Coventry, UK) and IBM SPSS Statistics
20 (IBM Corp, Armonk, NY).
Results
Forty-one paediatric CD patients previously treated with
EEN were identified and a total of 82 questionnaires
were posted to them and their parents. The returned
questionnaires (n = 58; response rate: 71%) provided in-
formation on 29 children [Median (IQR) age: 13.3
(11.1–15) years], of whom 20 (69%) were boys. The ma-
jority of them had successfully completed a course of
8 weeks on EEN (n = 23; 79%); 2 (7%) discontinued treat-
ment due to lack of response and 4 (14%) due to palat-
ability issues. Just over half of these children (n = 16;
55%) had to use nasogastric (NG) tube support during
the treatment course (Table 1). In all 29 cases, both the
child and a “parent” had completed the questionnaire,
however not all questions were completed by all respon-
dents (Table 2).
Almost two thirds of the patients and their parents
(n = 17; 59%) were positive on completing another
EEN course in the event of a future relapse, however
a higher proportion of participants thought an SFD
would be better than EEN (Patients: n = 19; 66%,
Parents: 21; 72%) (Table 2).
Table 1 Response rate, demographic characteristics and exclusive
enteral nutrition experience characteristics of paediatric Crohn’s
disease participants
Characteristics N (%)
Response rate 29 out of 41 (71)
Parental IBD history 3 (10)
Male gender 20 (69)
Completed 8 weeks EEN 23 (79)
Experienced EEN once 22 (76)
Repeated EEN courses 7 (24)
Use of NG tube 16 (55)
Median Age (IQR) 13.3 (11.1–15.0)
Abbreviations: IBD inflammatory bowel disease, EEN exclusive enteral nutrition,
NG nasogastric tube, IQR interquartile range
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Both patients and their parents rated (on a scale from
1–100) an actual EEN course to be significantly more
difficult when compared to the alternative proposed SFD
[Median (IQR) EEN vs SFD, Patients: 62 (17.8–83.8) vs
23 (6–46.5), p = 0.029, Parents: 50.5 (13.3–77) vs 26.5
(3.5–51), p = 0.026)] (Fig. 1). There were no significant
differences between patients’ and parents’ opinion (Fig. 1)
and their ratings were strongly correlated (EEN: r = 0.831,
SFD: r = 0749, both p < 0.001).
Participants generally agreed that if they needed to
undertake a further EEN course in a future relapse of
their disease, they would agree to participate in a clinical
trial comparing EEN with an SFD (Patients: n = 23; 79%,
Parents: n = 21; 72%). When we explained further the
design of a hypothetical RCT, and reported that the
development of a new dietary treatment could
decrease medication exposure, these percentages
remained equally high (Patients: n = 25; 86%, Parents:
n = 20; 69%) (Table 2).
To further explore these data, we split each of the pa-
tient and parent groups into 4 further subgroups based
on whether they completed their previous EEN course
or not and whether they used an NG tube during treat-
ment or not. This subanalysis revealed that participants
who failed treatment generally had a negative attitude to
an EEN repeat. In addition, participants who didn’t use
an NG tube had a more positive attitude towards the
use of an SFD (Table 2).
When these participants were asked to provide any
further comments on an open-ended question, we
Table 2 Frequencies of answers by paediatric CD patients and their parents (%Yes_%No_%n/a)
Total answers n = 29 Treatment failed
n = 6
Completed treatment
n = 23
Oral consumption
n = 13
Use of NG tube
n = 16
If you/your child had a further flare-up of CD, do you think you/they could complete another LD course?
P: 59_31_10
C: 59_31_10
P: 0_83_17
C: 0_83_17
P: 74_17_9
C: 74_17_9
P: 46_39_15
C: 54_39_8
P: 69_25_6
C: 63_25_13
Do you think an SFD would be better than the LD?
P: 72_14_14
C: 66_28_7
P: 83_0_17
C: 67_17_17
P: 70_17_13
C: 65_30_4
P: 85_8_8
C: 77_23_0
P: 63_19_19
C: 56_31_13
Would you be happy to participate in such a study if doctors felt you/they needed a repeat of the LD?
P: 79_17_4
C: 72_21_7
P: 50_33_17
C: 50_33_17
P: 87_13_0
C: 78_17_4
P: 77_23_0
C: 77_23_0
P: 81_13_6
C: 69_19_13
Would you/your child take the SFD beyond 8w if it was effective and meant less medication?
P: 86_7_7
C: 69_14_17
P: 83_0_17
C: 67_17_17
P: 87_9_4
C: 70_13_17
P: 92_0_8
C: 85_8_8
P: 81_13_6
C: 56_19_25
Total answers; split answers based on 8w treatment completion; split answers based on the method of enteral feeds delivery
Abbreviations: NG nasogastric tube, CD Crohn’s disease, LD liquid diet, SFD solid food-based diet, P parents, C children, n/a no answer
Fig. 1 Rating of exclusive enteral nutrition and solid food-based diet difficulty by Crohn’s disease patients and their parents using visual analogue
scales, translated to a scale from 1 to 100 (*p < 0.05 indicating statistically significant Wilcoxon signed-rank test between the two diets). EEN: Exclusive
Enteral Nutrition, SFD: Solid Food-based Diet, CD: Crohn’s Disease
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received 51 quotes on EEN and SFD (full quotes list
available on request). The majority of the EEN
comments were negative [positive vs negative vs neutral;
Parents: 4 (27%) vs 10 (67%) vs 1 (7%), Patients: 4 (33%)
vs 8 (67%) vs 0 (0%)]. The opposite was observed for the
SFD comments [Parents: 9 (60%) vs 3 (20%) vs 3 (20%),
Patients: 5 (56%) vs 4 (44%) vs 0 (0%)] (Fig. 2). Selected
quotes included: “the liquid-only diet was very isolating
at times for my child”; “my child found the liquid diet
easy as it was through the tube”; “I think an SFD would
be difficult to maintain without temptation”; “I think be-
ing on the SFD may make her feel more normal and part
of the family”.
Regarding the adult CD patients previously treated
with EEN over 1 year, 10 were identified of whom only 3
responded after the reminder letter. The responders’
perceptions towards the use of an SFD were similarly
positive to those of CD families but these data are not
presented due to the very low response rate.
Discussion
This survey delivers important insights on the EEN ex-
perience for families of children with CD and explores
the acceptability of an alternative hypothetical SFD. The
large majority of our participants would be happy to
repeat an EEN course during a further relapse of their
disease. This indicates that both patients and their carers
recognise the efficacy of EEN in CD management. The
modern use of more palatable polymeric feeds, and the
experience and training of health care professionals in-
volved in administering the treatment are known factors
increasing the acceptability of EEN [15, 16].
Despite the positive attitude to the use of EEN, most
respondents would preferentially agree to use an alterna-
tive SFD. The existing literature, describing patients’
frequent requests for dietary advice and exclusion of cer-
tain foods to prevent future relapses, is supportive of the
idea that an SFD would be well-received [17, 18].
CD patient perceptions were not different and strongly
correlated to those of their parents. This strong agree-
ment between parents and their chronically ill children
has been reported before [19]; however, there are strong
arguments that both opinions are of vital importance
and should be sought jointly [20].
The present survey is not without its limitations. Our
participants were asked to compare two different dietary
treatments, having experienced only the EEN before.
They therefore had to provide a hypothetical view on an
SFD, based on a provided exclusion diet template.
Additionally, only paediatric data are presented in the
current publication due to the poor response rate (30%)
in the adult CD patients approached for the reasons of
this survey. EEN use in adult CD patients is not a stand-
ard practice due to limited evidence of its efficacy in his-
torical datasets. Poor compliance mainly explained by
palatability issues is reported as the main reason for this
[4]. The low response rate among these patients could
be explained by their disease status, as according to the
current guidelines EEN use in adults is biased towards
patients with drug resistance or used as an adjunctive
therapy [21, 22]. Another potential source of bias is the
EEN completion rate within the 12 patients (29% non-
respondents) who did not return their questionnaires.
Lack of disease response on EEN course may differ be-
tween respondents and non-respondents and this was
not specifically examined in this cohort. The EEN com-
pletion rate within the 29 families included in our results
(79%) however is in broad agreement with previously
published rates from the same centre (75%), suggesting a
similar group [14].
Fig. 2 Comments received by Crohn’s disease patients and their parents regarding exclusive enteral nutrition and solid food-based diet. EEN:
Exclusive Enteral Nutrition, SFD: Solid Food-based Diet
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Conclusions
In conclusion, surveyed CD patients and their parents are
generally happy to repeat a course of EEN if needed, though
unsurprisingly this enthusiasm falls with previous EEN fail-
ure. Additionally, CD families surveyed are supportive of the
development and study of solid food-based dietary treat-
ments. This fits nicely with a well-described desire for diet-
ary modifications amongst the IBD patient community and
lends support towards developing a new paradigm of CD
dietary therapy, based on the success of EEN.
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